You are here » Home » Company » Neuland Laboratories Ltd

Neuland Laboratories Ltd.

BSE: 524558 Sector: Health care
NSE: NEULANDLAB ISIN Code: INE794A01010
BSE 00:00 | 18 Feb 442.50 -22.70
(-4.88%)
OPEN

453.00

HIGH

453.00

LOW

435.95

NSE 00:00 | 18 Feb 442.90 -20.10
(-4.34%)
OPEN

452.60

HIGH

461.00

LOW

437.35

OPEN 453.00
PREVIOUS CLOSE 465.20
VOLUME 1107
52-Week high 824.55
52-Week low 380.00
P/E 17.76
Mkt Cap.(Rs cr) 568
Buy Price 435.00
Buy Qty 31.00
Sell Price 454.00
Sell Qty 1.00
OPEN 453.00
CLOSE 465.20
VOLUME 1107
52-Week high 824.55
52-Week low 380.00
P/E 17.76
Mkt Cap.(Rs cr) 568
Buy Price 435.00
Buy Qty 31.00
Sell Price 454.00
Sell Qty 1.00

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd

Set up in 1984 as a private limited company to manufacture bulk drugs, Neuland Laboratories (NLL) is promoted by D R Rao. Neuland Drugs & Pharmaceuticals Pvt Ltd, a company set up by the same promoters to manufacture bulk drugs was merged with NLL with effect from Apr.'92. NLL manufactures bulk drugs such as salbutamol sulphate, terbutaline sulphate, labetalol hydrochloride and ciprofloxacin. ...> More

Neuland Laboratories Ltd - Key Fundamentals

Parameter Values
Market Cap ( cr)   568
EPS - TTM () [*S] 24.91
P/E Ratio (X) [*S] 17.76
Face Value ()   10
Latest Dividend (%)   20.00
Latest Dividend Date 18 Feb 2020
Dividend Yield (%) 0.26
Book Value / Share () [*S] 541.45
P/B Ratio () [*S] 0.82
[*C] Consolidated     [*S] Standalone    

Neuland Laboratories Ltd - Financial Results

Particulars ( cr) Dec 2019 Dec 2018 % Chg
Net Sales 203.84 171.48 18.87
Other Income 1.02 0.41 148.78
Total Income 204.87 171.88 19.19
Total Expenses 175.68 155.52 12.96
Operating Profit 29.18 16.37 78.25
Net Profit 11.11 4.69 136.89
Equity Capital 12.9 12.9 -
> More on Neuland Laboratories Ltd Financials Results

Neuland Laboratories Ltd - Peer Group

Company Price() Chg (%) Mkt Cap ( CR)
TTK Healthcare 489.70 3.68 691.95
Morepen Labs. 14.30 -4.03 643.29
Suven Life Scie. 48.70 4.96 619.95
Neuland Labs. 442.50 -4.88 567.73
Gufic BioScience 67.35 2.28 523.98
RPG LifeScience. 275.10 -2.46 454.95
Themis Medicare 430.00 -1.08 394.74
> More on Neuland Laboratories Ltd Peer Group

Neuland Laboratories Ltd - SHAREHOLDING PATTERN

Category Share (%)
Promoters 35.86
Banks/FIs 0.17
FIIs 27.17
Insurance 0.00
Mutual Funds 1.92
Indian Public 21.82
Custodians 0.00
Other 8.60
> More on Neuland Laboratories Ltd Share Holding Pattern

Neuland Laboratories Ltd - Research Reports

Date Broker Action Price Report
20/05 HDFC Securities Buy 669 PDF IconDetails
> More on Neuland Laboratories Ltd Research Reports

Neuland Laboratories Ltd - RETURNS

Period BSE NSE Sensex NIFTY
1 Week -9.48% -9.34% -0.78% -0.95%
1 Month -9.14% -8.92% -2.51% -2.91%
3 Month -8.85% -9.13% 1.51% 0.91%
6 Month -12.35% -12.18% 9.49% 8.55%
1 Year -23.24% -21.04% 15.20% 12.70%
3 Year -51.08% -51.05% 43.65% 35.94%

Neuland Laboratories Ltd - STOCK STRENGTH

Today's Low/High 435.95
453.00
Week Low/High 435.95
533.00
Month Low/High 420.00
533.00
YEAR Low/High 380.00
825.00
All TIME Low/High 13.63
1680.00